Wheatgrass, the young grass of common wheat (Triticum aestivum), has spent decades as a fixture of juice bars and wellness shelves, its reputation built more on enthusiasm than on pharmacology. A team of Indian pharmaceutical scientists has now given the emerald microgreen a far more rigorous assignment: packing its phytochemical payload into nanoscale droplets and suspending those droplets in a skin-friendly gel designed to carry the cargo deep into diseased tissue. In a study published in the journal Applied Nanoscience, Devendra Singh and Garima Garg of IIMT College of Medical Sciences at IIMT University in Meerut, working with Ramji Gupta of the R.V. Northland Institute in Greater Noida, describe the design and characterization of a wheatgrass-extract nanoemulsion locked inside a hydrogel—a hybrid system the field calls a nanoemulgel—aimed squarely at enhanced dermal targeting in skin cancer. The published numbers are striking: nanodroplets averaging roughly 121 nanometers, near-total extract release within 24 hours, permeation exceeding 95 percent across excised skin, and a safety profile that left skin-derived carcinoma cells largely unharmed at every concentration tested.
The formulation confronts one of dermatology’s most stubborn barriers: the skin itself. The stratum corneum, the outermost layer of the epidermis, is often described as a brick-and-mortar wall—flat, dead corneocytes stacked like bricks and mortared by highly organized sheets of lipids. That architecture is superb at keeping water in and foreign molecules out, which is precisely why ordinary creams and gels struggle to push therapeutic compounds much past the surface. Wheatgrass, meanwhile, is chemically rich but unruly: young wheat shoots contain chlorophyll, phenolic acids, flavonoids, proteins, amino acids, vitamins, and enzymes, a mixture repeatedly linked in the literature to antioxidant and chemopreventive activity. Yet as a raw extract it poses classic formulation headaches—limited solubility in both water and oil, susceptibility to degradation, and the tendency of complex botanical mixtures to precipitate, separate, or lose potency during storage. The team’s answer was to dissolve the extract inside an oil droplet so small that it behaves almost like a dissolved molecule, then embed that droplet population in a gel matrix that holds it against the skin long enough to work.
Building the system began with systematic screening. The researchers tested candidate ingredients for their ability to dissolve the wheatgrass extract and to emulsify it, and settled on three: orange oil as the internal oily phase, Tween 80 (polysorbate 80) as the primary surfactant, and Carbitol—diethylene glycol monoethyl ether—as the co-surfactant. Each choice has a chemical rationale. Orange oil, dominated by the terpene limonene, provides a lipophilic home for the extract and is itself regarded as a skin penetration enhancer capable of fluidizing the lipid packing of the stratum corneum. Tween 80, a nonionic surfactant, adsorbs at the oil–water interface and drives interfacial tension low enough that minute droplets can persist without coalescing. Carbitol, a glycol ether solvent, wedges into that interfacial film, loosens it further, and can likewise ease the barrier lipids of the skin itself. The paired surfactant–co-surfactant system is termed Smix, and its internal ratio is decisive. By mapping compositions of oil, Smix, and water on pseudoternary phase diagrams, the team identified the 2:1 Tween 80-to-Carbitol ratio as producing the largest monophasic nanoemulsion region—the widest window of compositions that remain a clear, single-phase, droplet-based system rather than splitting back into layers.
Within that window, emulsification was driven by ultrasonication, a technique in which high-frequency sound waves nucleate microscopic vapor bubbles in the liquid; when those bubbles collapse, they release intense local shear that shreds oil droplets into the nanometer range. From a series of trial formulations, F3 emerged as the optimum. Its droplets averaged 121.48 nanometers—small enough to weave through the tortuous channels between corneocytes and, in principle, to enter follicular openings—while its polydispersity index of 0.251 confirmed a reasonably uniform population rather than a smear of sizes. PDI values below roughly 0.3 are conventionally taken to indicate narrow, well-controlled distributions, a critical property because broad distributions invite Ostwald ripening, in which small droplets dissolve and feed the growth of larger ones until the nanoscale character is lost. Zeta potential, the electrical potential at the droplet surface, registered −26.29 millivolts. A surface charge of that magnitude means neighboring droplets repel one another electrostatically, and values beyond roughly 25 to 30 millivolts are widely associated with colloidal systems that resist aggregation—another safeguard against the coarsening that would destroy nanoemulsion behavior.
Stability was then interrogated with a battery of deliberately abusive stress tests. The formulation endured heating–cooling cycles that alternate elevated and chilled temperatures, centrifugation at forces strong enough to compress any tendency to cream or sediment, and freeze–thaw cycling that drives ice formation and osmotic shock through the droplets. In every challenge the nanoemulsion held: no phase separation, no cracking, no creaming. For a botanical extract, whose constituents can interact unpredictably with surfactants over months of storage, that robustness is not a cosmetic detail; it is the difference between a laboratory curiosity and a product that survives warehousing, shipping, and a bathroom shelf. The authors report that the formulation remained thermodynamically stable across all three stress modes, an outcome consistent with the tight, elastic interfacial film that a 2:1 surfactant-to-co-surfactant ratio produces around each droplet.
Converting the flowing nanoemulsion into a wearable dosage form came next, with Carbopol 940 chosen as the gelling agent—a crosslinked polyacrylic acid polymer that swells into a clear gel network upon neutralization. Dispersing the nanoemulsion through this matrix yielded the final nanoemulgel, whose physicochemical dossier the authors report in detail. Its pH of 6.48 ± 0.12 lies within the mildly acidic range tolerated by healthy skin, limiting the sting and irritation that off-pH topicals can provoke. Viscosity measured 4870 ± 25 centipoise—thick enough to stay on the application site, fluid enough to spread without tacky resistance—and the gel displayed good spreadability and visual homogeneity, the practical markers of a formulation patients will actually use correctly. Most telling was drug content: 96.38 percent of the theoretical wheatgrass extract load was recovered in the finished gel, showing that emulsification and gelation consumed almost none of the payload—a frequent failure point when fragile botanical actives are processed at scale.
Performance followed. In release experiments, the nanoemulgel liberated 95.11 percent of its extract payload over 24 hours, compared with 86.42 percent from the standard gel formulation—a gap the authors attribute to the enormous interfacial area of nanodroplets, which keeps a large fraction of the extract dissolved at droplet surfaces and ready to partition outward rather than locked inside coarse particles. Permeation was then examined across excised skin, the standard ex vivo bridge between a dissolution test and animal work. Over 24 hours, the nanoemulgel drove 95.08 percent of the extract through the skin tissue, and—critically for a dermally targeted product—deposited 1041.49 micrograms per square centimeter within the skin itself, markedly more than the conventional gel achieved. Retention matters as much as passage: a topical anticancer product wants high concentrations resident in the epidermis and dermis, where lesions reside, while minimizing systemic spillover. The nanoemulgel’s combination of high permeation and high deposition points to exactly that depot behavior, with the surfactant blend and nanoscale droplet size serving as the penetration engines.
Safety was evaluated against A431 cells, a widely used human epidermoid carcinoma line that models skin cancer. The cytotoxicity data showed the test formulation was well tolerated: cell viability remained above 50 percent, and the half-maximal inhibitory concentration, or IC50, of the nanoemulgel exceeded 5624 micrograms per milliliter—the highest concentration examined. In practical terms, even at the top of the tested dose range, the formulation failed to kill half of the cells, signaling a wide margin between topical use and toxicity for a vehicle intended for repeated application to compromised skin. The distinction the authors preserve matters: these experiments establish the delivery system’s biocompatibility rather than proving that wheatgrass bioactives destroy tumors. Antitumor efficacy is a separate question that will require dedicated testing. But for a platform whose ambition is dermal targeting in skin cancer, demonstrating that the carrier itself adds no cytotoxic burden is the essential first gate, and the nanoemulgel cleared it.
The work sits within a fast-growing movement to give plant-derived medicines the delivery science that synthetic drugs routinely receive. Herbal extracts are cheap, renewable, and biochemically rich, but notoriously hard to standardize: variable harvests, complex mixtures, and unstable actives make dosing inconsistent. Nanoformulation attacks those weaknesses directly—confining an extract inside uniform droplets with measured size, charge, and release kinetics converts a folk remedy into an engineered dosage form. The paper’s keyword list, which includes liquid chromatography–mass spectrometry, or LC-MS, signals the analytical rigor such characterization demands. The caveats, however, are real. Everything reported here is in vitro or ex vivo: release, permeation across excised skin, and cell-line cytotoxicity. Clinical credibility will require in vivo efficacy studies in animal models of skin lesions, pharmacokinetic and toxicological profiling, long-term stability data, and eventually controlled human trials. Skin cancer’s established arsenal—surgery, cryotherapy, radiotherapy, and proven topical agents such as 5-fluorouracil and imiquimod—will not be displaced by a wheatgrass gel any time soon; the realistic near-term role for such systems is adjunctive or supportive, particularly where mild, plant-based, well-tolerated topicals are sought.
What the study does establish is a complete, reproducible recipe: solubility-driven excipient selection, a phase-diagram-guided surfactant ratio, ultrasonication for size control, Carbopol-based gelation, and a full physicochemical and biological audit. The authors, who received no external funding for the work, frame the wheatgrass nanoemulgel as a safe and effective dermally directed delivery system, with supporting data available from the corresponding author upon reasonable request. The next chapters—animal efficacy models, dose finding, and clinical evaluation—remain to be written. Yet the paper is a tidy demonstration of how the boundaries between agriculture, cosmetic chemistry, and nanomedicine are dissolving: food-grade orange oil, a cosmetic-grade surfactant, and a juice-bar icon converge into a pharmaceutical prototype. Wheatgrass’s second act, it seems, will unfold not in a wellness shot glass but inside a 121-nanometer droplet, waiting to be tested against one of medicine’s most visible diseases.
Subject of Research: Development and characterization of a wheatgrass extract nanoemulsion-based hydrogel (nanoemulgel) for enhanced dermal targeting in skin cancer
Subject of Research: Technology and Engineering
Article Title: Design and characterization of wheatgrass extract Nanoemulsion-Based hydrogel for enhanced dermal targeting in skin cancer
Article References: Singh, D., Garg,, G., & Gupta, R. (2026). Design and characterization of wheatgrass extract Nanoemulsion-Based hydrogel for enhanced dermal targeting in skin cancer. Applied Nanoscience, 16(2), Article 16. https://doi.org/10.1007/s13204-026-03150-0
Image Credits: AI Generated
DOI: 10.1007/s13204-026-03150-0
Keywords: wheatgrass extract, nanoemulsion, nanoemulgel, ultrasonication, Smix ratio, pseudoternary phase diagram, skin permeation, LC-MS, A431 cells, topical delivery
Cite Scienmag News
APA
MLA
Chicago
Nathaniel Bowman. (August 30, 2026). Wheatgrass extract nanoemulsion hydrogel enhances dermal targeting against skin cancer. Scienmag. https://scienmag.com/wheatgrass-extract-nanoemulsion-hydrogel-enhances-dermal-targeting-against-skin-cancer/
Nathaniel Bowman. “Wheatgrass extract nanoemulsion hydrogel enhances dermal targeting against skin cancer.” Scienmag, 30 August 2026, https://scienmag.com/wheatgrass-extract-nanoemulsion-hydrogel-enhances-dermal-targeting-against-skin-cancer/. Accessed 30 August 2026.
Nathaniel Bowman. “Wheatgrass extract nanoemulsion hydrogel enhances dermal targeting against skin cancer.” Scienmag. August 30, 2026. https://scienmag.com/wheatgrass-extract-nanoemulsion-hydrogel-enhances-dermal-targeting-against-skin-cancer/
Copy citation
Download RIS
Tags: advanced nanomedicine for dermatologydermal drug delivery systems for skin cancerdevelopmentenhanced skin penetration of plant extractsnanocarrier safety profile in dermatologynanoemulgel formulation and characterizationnanoemulgel formulation for skin targetingnanoscale drug targeting for dermatological applicationsnanoscale phytochemical deliverynanotechnology in skin cancer therapeuticsnanotechnology in skin cancer therapynatural plant extracts for cancer treatmentovercoming skin barrier with nano-sized drug carriersovercoming stratum corneum barrier with nanoemulsionsphytochemical nanoencapsulation in hydrogelsphytochemical-loaded nanodroplets for dermal applicationsafety and efficacy of nanoemulsion-based topical treatmentsskin cancer treatment using nanotechnologyskin permeation enhancement techniquesskin permeation of nanoemulsionstopical nanoemulsion hydrogelWheatgrass extract nanoemulsion hydrogel
